Drawing for BMUNE

USPTO serial 90899802

BMUNE

Status 661
Filing date
Aug 24, 2021
Status date
Aug 27, 2026
Registration date
Examiner
RICKS, AUDREY NICOLE

Need help with BMUNE?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Owner

  • Golestani, Shohre

    Sacramento, CA, US

Goods and services

ClassDescriptionStatusFirst use
005Nutraceuticals for boosting the immune system; pharmaceutical preparations for treating and/or preventing infectious diseases, cancer, allergies, antiviral, and/or autoimmune diseasesACTIVE

Prosecution history

DateCodeEvent
Aug 27, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2026GNRTNON-FINAL ACTION E-MAILED
Jun 26, 2026CNRTNON-FINAL ACTION WRITTEN
May 21, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 14, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 13, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 6, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 3, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 1, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 28, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 28, 2022GNSLLETTER OF SUSPENSION E-MAILED
Oct 28, 2022CNSLSUSPENSION LETTER WRITTEN
Sep 14, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2022GNRTNON-FINAL ACTION E-MAILED
Jun 2, 2022CNRTNON-FINAL ACTION WRITTEN
May 26, 2022DOCKASSIGNED TO EXAMINER
Oct 10, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related guidance